Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong revenue projections and growth drivers, notably in OCS and CPO segments, which are promising. However, significant supply-demand imbalances and constraints, particularly in EMLs and laser supply, raise concerns. Management's unclear responses on key details further add uncertainty. The market cap suggests a moderate reaction, leading to a neutral prediction.
Revenue $808 million, a 90% year-over-year increase, driven by growth in the transceiver business and laser chips.
Non-GAAP Operating Margin 32.2%, up 2,140 basis points year-over-year, due to a rich product mix and strong operating leverage.
Components Revenue $533 million, a 77% year-over-year growth, driven by shipments of narrow linewidth laser assemblies (120% year-over-year growth) and pump lasers (80% year-over-year growth).
Systems Revenue $275 million, a 121% year-over-year increase, primarily driven by cloud transceivers (40% sequential growth).
Non-GAAP Gross Margin 47.9%, up 1,270 basis points year-over-year, due to better manufacturing utilization, increased pricing on select products, and favorable product mix.
Non-GAAP Operating Profit $260.7 million, reflecting revenue growth in components products and cost controls.
Adjusted EBITDA $293.5 million, reflecting strong operational performance.
Non-GAAP Net Income $225.7 million, driven by revenue growth and operational efficiency.
GAAP Gross Margin 44.2%, reflecting improved manufacturing utilization and product mix.
GAAP Operating Margin 21.6%, reflecting revenue growth and operational efficiency.
GAAP Net Income $144.2 million, reflecting overall business growth.
CapEx $125 million, primarily focused on manufacturing capacity to support cloud and AI customers.
Transceiver Business and Laser Chips: Revenue grew 90% year-over-year to $808 million, driven by transceiver business and laser chips. Narrow linewidth laser assemblies grew 120% year-over-year, and pump laser shipments grew 80% year-over-year.
EML Shipments: Achieved a company record in EML shipments, with 200-gig EML revenue more than doubling sequentially. CW lasers for internal use in cloud transceiver business began in fiscal Q3.
Ultra-High-Power Laser Chips: Manufacturing ramp for CPO applications is proceeding as planned, with meaningful revenue expected in December quarter and a multi-hundred million dollar purchase order for 2027.
Acquisition of Indium Phosphide Fab: Acquired a fifth indium phosphide fab in Greensboro, North Carolina, to support future growth and U.S. manufacturing.
Cloud Transceivers: Cloud transceivers accounted for significant growth, increasing over 40% sequentially. Poised to ramp 1.6T-speed transceiver shipments in fiscal Q4.
Manufacturing Footprint Expansion: Expanded manufacturing footprint in Thailand to support cloud transceivers. Improved profitability through better yields and lower scrap rates.
Wafer Fab Capacity: Wafer fab capacity in Japan remains fully allocated to meet surging demand, with plans to achieve over 50% growth in EML units by December 2026.
Scale-Across Portfolio: Focus on scale-across networks to expand gross and operating margins. Emerging multi-rail technology will support increased parallelism in massive fiber counts.
Long-Term Agreements: Actively working to secure long-term agreements to offset anticipated capital expenditures.
Supply Chain Constraints: Critical component shortages are limiting the company's ability to meet customer demand, particularly in the transceiver and optical switch product areas. This is causing tension in the roadmap and forcing prioritization of resources.
Manufacturing Capacity: Wafer fab capacity in Japan is fully allocated, and the company is working to secure long-term agreements to offset anticipated capital expenditures. This could impact the ability to meet surging customer demand.
Product Development Tensions: The significant increase in demand for optical switches is putting pressure on the company's roadmap, requiring difficult choices in resource allocation.
Economic and Capital Expenditure Risks: The company is investing heavily in manufacturing capacity and R&D, which could pose financial risks if market conditions or demand projections change.
Regulatory and Operational Risks: The acquisition and conversion of the Greensboro facility to indium phosphide manufacturing involves operational complexities and potential regulatory hurdles.
Revenue Projections: Lumentum anticipates net revenue for Q4 FY26 to be in the range of $960 million to $1.01 billion, with a midpoint of $985 million, representing a new all-time quarterly revenue record.
Operating Margin: Non-GAAP operating margin for Q4 FY26 is projected to be in the range of 35% to 36%.
Earnings Per Share (EPS): Diluted non-GAAP EPS for Q4 FY26 is expected to range between $2.85 and $3.05.
Revenue Growth Drivers: Over half of the sequential growth in Q4 is expected to come from the components business, with the remainder driven by the ramp-up of the systems portfolio, particularly high-speed transceivers and contributions from OCS.
Long-Term Revenue Goal: The company remains confident in achieving its $2 billion quarterly revenue goal as outlined at the OFC event.
Component Business Growth: Lumentum expects over 50% growth in EML units by December 2026 compared to December 2025, driven by strong demand for laser chips and components.
Capital Expenditures: The company is actively working to secure long-term agreements to offset anticipated capital expenditures.
Cloud and AI Revenue: Inventory levels have increased to support expected growth in cloud and AI-related revenue.
CPO Applications: The ultra-high-power laser chip manufacturing ramp for CPO applications is proceeding as planned, with meaningful revenue expected in the December quarter and a multi-hundred million dollar purchase order slated for the first half of 2027.
Indium Phosphide Fab Expansion: The acquisition of a fifth indium phosphide fab in Greensboro, North Carolina, is expected to provide capacity for years of future growth.
The selected topic was not discussed during the call.
The earnings call highlights strong revenue projections and growth drivers, notably in OCS and CPO segments, which are promising. However, significant supply-demand imbalances and constraints, particularly in EMLs and laser supply, raise concerns. Management's unclear responses on key details further add uncertainty. The market cap suggests a moderate reaction, leading to a neutral prediction.
The earnings call highlights strong financial metrics, including record revenue projections and robust growth drivers in cloud transceivers and optical technologies. Despite some unclear management responses, the Q&A session reveals positive market sentiment, with strong demand and strategic LTAs in place. The company is addressing capacity constraints and has a significant CPO order, suggesting a favorable outlook. The market cap indicates moderate sensitivity to news, supporting a positive stock price movement prediction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.